The Humanized CD40 Antibody SGN-40 Demonstrates Pre-clinical Activity That is Enhanced By Lenalidomide in Chronic Lymphocytic Leukemia

Antibody-based therapies, such as rituximab and alemtuzumab, have contributed significantly to the treatment of Chronic Lymphocytic leukemia (CLL). The CD40 antigen is expressed predominantly on B-cells and represents a potential target for immune-based therapies. SGN-40 is a humanized IgG1 monoclon...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Lapalombella, Rosa, Gowda, Aruna, Joshi, Trupti, Mehter, Najma, Cheney, Carolyn, Lehman, Amy, Chen, Ching-Shih, Johnson, Amy J., Caligiuri, Michael A., Tridandapani, Susheela, Muthusamy, Natarajan, Byrd, John C.
格式: Artigo
語言:Inglês
出版: 2009
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2776067/
https://ncbi.nlm.nih.gov/pubmed/19183192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2008.07548.x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍